BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Berg T, Benhamou Y, Calleja JL, Levrero M, Johnson W, Ellis N. A survey of chronic hepatitis B patient management practices in the European Union. J Viral Hepat. 2010;17:624-630. [PMID: 20487257 DOI: 10.1111/j.1365-2893.2010.01318.x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Fan CX, Li XF, Zhan YF, Zheng QY, Feng Q, Shi XY, Li YJ, Tan HB. Efficacy and safety of interferon α-2b as an add-on therapy to long-term oral nucleotide analogue therapy in hepatitis B e antigen-negative patients. Shijie Huaren Xiaohua Zazhi 2017; 25(11): 983-988 [DOI: 10.11569/wcjd.v25.i11.983] [Reference Citation Analysis]
2 McKeage K, Keam SJ. Telbivudine: a review of its use in compensated chronic hepatitis B. Drugs. 2010;70:1857-1883. [PMID: 20836578 DOI: 10.2165/11204330-000000000-00000] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]